Dr. Minah Kim is a tenure-track faculty member in Pathology and Cell Biology at Columbia University Irving Medical Center, where she began her appointment in 2019. She earned her PhD from KAIST under the mentorship of Dr. Gou Young Koh and completed her postdoctoral training in the lab of Dr. Donald McDonald at UCSF. Her research focuses on vascular destabilization as a niche for facilitating distant metastasis, particularly in the development of resistance to anti-angiogenic therapy. Additionally, her work explores vascular-immune crosstalk to understand how the vasculature regulates the immune microenvironment and influences responses to immunotherapy. Beyond cancer, her lab investigates vascular regulation of disease pathogenesis and progression in Alzheimer’s disease.
